Prestige Consumer Healthcare PBH
$49.63 +$0.03 (+0.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $49.63 0.00%
Open$49.85
Prev close$49.60
Day range$49.43 – $51.23
Volume612.4K
Market cap$2.35B
P/E (TTM)15.3
Dividend yield–
Earnings
Average move on report day±6.3%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+14.8%
Worst reaction-16.8%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2027/Q2 | 5 Nov 2026 | Pre Market | ±10.0% | -16.82% | Bigger than priced |
| 2027/Q1 | 6 Aug 2026 | Pre Market | ±9.3% | +2.74% | Within range |
| 2026/Q4 | 13 May 2026 | After Market | ±9.5% | -11.35% | Bigger than priced |
| 2026/Q3 | 5 Feb 2026 | Pre Market | ±5.3% | -2.21% | Within range |
| 2026/Q2 | 6 Nov 2025 | Pre Market | ±8.5% | +2.56% | Within range |
| 2026/Q1 | 7 Aug 2025 | Pre Market | – | -10.05% | – |
| 2025/Q4 | 8 May 2025 | Pre Market | – | +6.92% | – |
| 2025/Q3 | 6 Feb 2025 | Pre Market | – | +14.78% | – |
| 2025/Q2 | 7 Nov 2024 | Pre Market | – | +3.16% | – |
| 2025/Q1 | 8 Aug 2024 | Pre Market | – | -1.55% | – |
| 2024/Q4 | 14 May 2024 | After Market | ±3.8% | -7.01% | Bigger than priced |
| 2024/Q3 | 8 Feb 2024 | Pre Market | ±4.9% | +9.36% | Bigger than priced |
| 2024/Q2 | 2 Nov 2023 | Pre Market | ±16.2% | -0.57% | Within range |
| 2024/Q1 | 3 Aug 2023 | Pre Market | – | +0.94% | – |
| 2023/Q4 | 4 May 2023 | Pre Market | – | +1.26% | – |
| 2023/Q3 | 2 Feb 2023 | Pre Market | ±7.3% | -8.82% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2027/Q2
By business line
Fundamentals
Latest reported quarter: Q2, ended Sep 2026
Revenue$336.31M+22.7% YoY
Operating profit$80.71M+1.3% YoY
Net profit$25.30M-40.1% YoY
Diluted EPS$0.53-38.4% YoY
Free cash flow$34.24M-38.2% YoY
Operating cash flow$37.87M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin52.5%
Operating margin25.0%
Net margin13.3%
Return on equity8.2%
Return on assets3.8%
Return on invested capital5.9%
Current ratio2.92
Liabilities / assets58.8%
Cash & investments$46.52M
Total debt$2.12B
Net cash (debt)-$2.07B
Free cash flow / sales18.4%
No comments yet — be the first to weigh in on PBH.
Sign in to join the discussion.